Christine Thoens1, Christoph Berger2, Martin Trippler3, Holger Siemann4, Melanie Lutterbeck3, Ruth Broering3, Jörg Schlaak3, Falko M Heinemann5, Andreas Heinold5, Jacob Nattermann6, Norbert Scherbaum4, Galit Alter2, Joerg Timm7. 1. Institute of Virology, University of Duisburg-Essen, University Hospital, Essen, Germany. 2. The Ragon Institute of MGH, MIT and Harvard, Boston, USA. 3. Department for Gastroenterology and Hepatology, University of Duisburg-Essen, University Hospital, Essen, Germany. 4. Addiction Research Group, Department of Psychiatry and Psychotherapy, Rhine State Hospital, Hospital of the University of Duisburg-Essen, Essen, Germany. 5. Institute for Transfusion Medicine, University of Duisburg-Essen, University Hospital, Essen, Germany. 6. Department of Internal Medicine, University of Bonn, Bonn, Germany. 7. Institute of Virology, University of Duisburg-Essen, University Hospital, Essen, Germany. Electronic address: joerg.timm@uni-due.de.
Abstract
BACKGROUND & AIMS: Despite continuous high-risk behavior, a subgroup among people who inject drugs (PWID) remains seronegative for hepatitis C virus (HCV) suggesting that a state of "natural resistance" to HCV Infection may exist. Homozygosity for KIR2DL3 and its ligand HLA-C1 group alleles has been associated with control of HCV infection, however, the mechanism mediating this protective effect remained unclear. METHODS: Peripheral NK cells from PWID (n=104) were phenotypically and functionally characterized by multicolor flow cytometry. Expression levels of the NK cell receptor ligands were analysed in liver biopsies and primary human hepatocytes. RESULTS: HCV seronegative PWID (n=34) had increased levels of KIR2DL3(+)NKG2A(-) NK cells compared to healthy controls (n=10; p<0.001) and PWID with chronic (n=38; p<0.001) or resolved infection (n=37; p<0.001). There was an inverse correlation between the frequency of KIR2DL3(+) and NKG2A(+) NK cells (r=-0.53; p<0.0001). Importantly, expression of HLA-E, the ligand for NKG2A, was significantly upregulated in liver biopsies of HCV infected patients (n=51) compared to HBV infected patients (n=22; p<0.01) and correlated with HCV viral load (r=0.32; p<0.0029). In functional analyses KIR2DL3(-)NKG2A(+) NK cells but not KIR2DL3(+)NKG2A(-) NK cells were significantly inhibited by HLA-E ligation. Accordingly, interferon gamma secretion of NK cells from PWID with chronic infection but not from HCV seronegative PWID was significantly suppressed in the presence of HLA-E. CONCLUSIONS: KIR2DL3(+)NKG2A(-) NK cells are not sensitive to HLA-E-mediated inhibition and may thereby control early HCV infection prior to seroconversion and result in an apparent state of "natural resistance" to HCV in PWID.
BACKGROUND & AIMS: Despite continuous high-risk behavior, a subgroup among people who inject drugs (PWID) remains seronegative for hepatitis C virus (HCV) suggesting that a state of "natural resistance" to HCV Infection may exist. Homozygosity for KIR2DL3 and its ligand HLA-C1 group alleles has been associated with control of HCV infection, however, the mechanism mediating this protective effect remained unclear. METHODS: Peripheral NK cells from PWID (n=104) were phenotypically and functionally characterized by multicolor flow cytometry. Expression levels of the NK cell receptor ligands were analysed in liver biopsies and primary human hepatocytes. RESULTS:HCV seronegative PWID (n=34) had increased levels of KIR2DL3(+)NKG2A(-) NK cells compared to healthy controls (n=10; p<0.001) and PWID with chronic (n=38; p<0.001) or resolved infection (n=37; p<0.001). There was an inverse correlation between the frequency of KIR2DL3(+) and NKG2A(+) NK cells (r=-0.53; p<0.0001). Importantly, expression of HLA-E, the ligand for NKG2A, was significantly upregulated in liver biopsies of HCV infectedpatients (n=51) compared to HBV infectedpatients (n=22; p<0.01) and correlated with HCV viral load (r=0.32; p<0.0029). In functional analyses KIR2DL3(-)NKG2A(+) NK cells but not KIR2DL3(+)NKG2A(-) NK cells were significantly inhibited by HLA-E ligation. Accordingly, interferon gamma secretion of NK cells from PWID with chronic infection but not from HCV seronegative PWID was significantly suppressed in the presence of HLA-E. CONCLUSIONS:KIR2DL3(+)NKG2A(-) NK cells are not sensitive to HLA-E-mediated inhibition and may thereby control early HCV infection prior to seroconversion and result in an apparent state of "natural resistance" to HCV in PWID.
Authors: Peter D Krueger; Sowmya Narayanan; Fionna A Surette; Michael G Brown; Sun-Sang J Sung; Young S Hahn Journal: J Leukoc Biol Date: 2016-08-04 Impact factor: 4.962
Authors: I Lisovsky; G Isitman; A Tremblay-McLean; R Song; S DaFonseca; B Lebouchẻ; J-P Routy; J Bruneau; N F Bernard Journal: Clin Exp Immunol Date: 2016-09-09 Impact factor: 4.330
Authors: Jeffrey R Quinn; Ashish Goyal; Ruy M Ribeiro; Guido Massaccesi; Justin R Bailey; David L Thomas; Ashwin Balagopal Journal: AIDS Date: 2022-03-01 Impact factor: 4.632